Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition containing beta-lactamase restrainer and piperacillin sodium with steady content and preparation method thereof

A technology of lactamase and composition, which is applied in the direction of medical preparations containing active ingredients, pharmaceutical formulas, active ingredients of heterocyclic compounds, etc., can solve the problems of polluting liquid medicine, increasing drug pollution, milky white turbidity, etc., and achieve the elimination of medical treatment Hidden dangers of accidents, remarkable clinical curative effect, and the effect of solution clarification

Active Publication Date: 2010-06-02
福建丰恺思投资有限公司 +1
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This invention has the following disadvantages: the composite preparation of piperacillin sodium and tazobactam sodium must be dissolved in a diluent for clinical use, and the most commonly used diluent for dissolving clinically is 5% or The pH value of 10% glucose injection and 5% glucose saline solution is about 3.8, both of which are slightly acidic. After using this infusion solution to dissolve the compound preparation of piperacillin sodium and tazobactam sodium, the pH value of the infusion solution at this time is 4.0 Left or right, piperacillin sodium will reversibly precipitate and produce insoluble or milky white turbidity. medical malpractice
But there are following problems in this method: 1, this method just accelerates dissolution speed with physical method, when ambient temperature is low 10 degrees, can not solve the dissolution problem of piperacillin sodium completely; 2, must select water for injection or 0.9 % sodium chloride solution instead of acidic glucose solution or 5% glucose saline, otherwise it will still not dissolve
3. It does not help to solve the problem that the content of piperacillin sodium in the solution decreases and the potency decreases
But no matter how it is packed, one bottle or two bottles still have following deficiencies that cannot be solved: 1, because the pH value of the pharmaceutical composition of β-lactamase inhibitor and piperacillin sodium is the most stable when 4.5~6.5, The range is very narrow, as long as a small amount of alkali can make the pH of the solution exceed 6.5, thereby destroying the lactam ring structure of piperacillin sodium, producing by-products, and causing adverse reactions
Therefore the consumption of alkali must be strictly controlled, and such a small amount (a few tenths of milligrams) is difficult to be produced into a separate bottle of B under current production conditions; It is very troublesome, and the back-and-forth puncture of the needle increases the chance of drug contamination; 3. During the dissolving process of dispensing, the commonly used co-solvent sodium carbonate or sodium bicarbonate will generate gas, which will increase the pressure in the bottle
Due to the high internal pressure of the bottle, it is easy to push the needle piston out during the drug pumping process, or there is liquid overflow from the ventilation tube in the early stage of infusion, resulting in insufficient dosage or drug contamination; 4. Sodium carbonate or carbonic acid as a cosolvent Sodium hydrogen is a weak acid and strong base compound. When dissolved in an acidic solution, it can react to release CO 2
However, commonly used clinical infusions such as 5% glucose solution, 10% glucose injection, and 5% glucose saline are acidic, so sodium carbonate or sodium bicarbonate is used as a cosolvent, and CO will be continuously produced during the dilution process. 2 Gas, if the exhaust operation is improper, it may contaminate the liquid medicine, and the CO in the process of infusion to the patient 2 Air bubbles entering the patient's blood may form a gas embolism. If the blockage occurs in the main blood vessels of the heart and brain, it will cause great danger to the patient.
[0007] The above problems have seriously affected the clinical use of the compound preparation of piperacillin sodium and β-lactamase inhibitors, and have not been fundamentally and effectively solved so far.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition containing beta-lactamase restrainer and piperacillin sodium with steady content and preparation method thereof
  • Pharmaceutical composition containing beta-lactamase restrainer and piperacillin sodium with steady content and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Add piperacillin sodium 100g, sulbactam sodium 100g and mannitol 50g in 100ml of water for injection, stir and make it dissolve, measure the pH value, add 115ml with the aqueous solution of sodium hydroxide of 0.1mol / l concentration with titration, Adjust the pH to 6.5. Stir to dissolve completely, sterile filter, potting, freeze-drying in a freeze dryer, pre-freezing, decompression, sublimation, drying, plugging, and capping to obtain the freeze-dried preparation 100 of the pharmaceutical composition of the present invention. bottle.

Embodiment 2

[0029] Add 100 g of piperacillin sodium, 100 g of tazobactam sodium and 50 g of mannitol into 60 ml of water for injection, stir to dissolve it, measure the pH value, add 190 ml of sodium carbonate aqueous solution with a concentration of 0.1mol / l in a titration mode, adjust The pH is 6.4. Stir to dissolve, sterile filter, potting, freeze-drying in a freeze dryer, pre-freezing, decompression, sublimation, drying, plugging, and capping to obtain 100 bottles of the freeze-dried preparation of the pharmaceutical composition of the present invention .

Embodiment 3

[0031] With piperacillin sodium 100g, sulbactam sodium 50g and sorbitol 30g, add in the water for injection 90ml, stir and make it dissolve, measure pH value, add 110ml with the aqueous solution of sodium bicarbonate of 0.2mol / l concentration with titration, Adjust the pH to 6.3. Stir to dissolve, sterile filter, potting, freeze-drying in a freeze dryer, pre-freezing, decompression, sublimation, drying, plugging, and capping to obtain 100 bottles of the freeze-dried preparation of the pharmaceutical composition of the present invention .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a stable-content drug compound containing Beta-lactamases inhibitors and piperacillin sodium and the preparation method thereof. The drug compound consists of piperacillin sodium, Beta-lactamases inhibitors and pH-value regulators with the weight proportion of 1 to 100:1:0.001 to 2. Diluted and delivered in any proportion with conventional clinical transfusions, the drug compound can have a stable piperacillin sodium content, dissolve rapidly, generate no crystallization or degradation products and receive no effect from the temperature. The preparation method of the stable-content drug compound containing Beta-lactamases inhibitors and piperacillin sodium has simple preparing method and high efficiency and is fit for a large-scale industrial production.

Description

technical field [0001] The invention relates to a pharmaceutical composition with stable content of active ingredients. Specifically, it relates to a drug that can maintain stable content of piperacillin sodium when it is diluted with all clinical routine infusion solutions in any ratio, and dissolves quickly, does not produce crystals and degradation products, and is not affected by temperature. A pharmaceutical composition comprising a beta-lactamase inhibitor and piperacillin sodium. Background technique [0002] Piperacillin sodium is a semi-synthetic penicillin antibiotic with broad antibacterial spectrum and few side effects, and is widely used in clinic. However, in the course of clinical application, it was found that the compound preparation containing piperacillin sodium and β-lactamase inhibitor dissolved in the infusion would often appear turbid, and the content of piperacillin sodium decreased, so the use was terminated. Especially in winter and spring in the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/431A61K31/424A61K31/43A61K9/19A61P31/04
Inventor 郑飞雄
Owner 福建丰恺思投资有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products